Integrity Alliance LLC. purchased a new stake in shares of National Research Corporation (NASDAQ:NRC – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 25,393 shares of the company’s stock, valued at approximately $538,000.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Farmers & Merchants Investments Inc. grew its stake in National Research by 51.7% during the third quarter. Farmers & Merchants Investments Inc. now owns 501,731 shares of the company’s stock worth $10,632,000 after buying an additional 171,082 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in shares of National Research by 4.0% during the first quarter. Bank of New York Mellon Corp now owns 250,707 shares of the company’s stock worth $4,257,000 after buying an additional 9,730 shares in the last quarter. Heartland Advisors Inc. raised its stake in shares of National Research by 374.3% in the first quarter. Heartland Advisors Inc. now owns 237,147 shares of the company’s stock valued at $4,027,000 after acquiring an additional 187,147 shares during the last quarter. Bank of America Corp DE raised its stake in shares of National Research by 3.0% in the first quarter. Bank of America Corp DE now owns 112,468 shares of the company’s stock valued at $1,910,000 after acquiring an additional 3,323 shares during the last quarter. Finally, Fifth Third Bancorp bought a new position in shares of National Research in the first quarter valued at approximately $1,531,000. 47.26% of the stock is currently owned by institutional investors and hedge funds.
National Research Stock Up 1.5%
Shares of NASDAQ:NRC opened at $25.86 on Friday. National Research Corporation has a 12 month low of $11.73 and a 12 month high of $27.41. The company’s 50-day moving average price is $21.55 and its two-hundred day moving average price is $19.30. The company has a quick ratio of 0.65, a current ratio of 0.64 and a debt-to-equity ratio of 13.13. The firm has a market cap of $588.32 million, a P/E ratio of 92.36 and a beta of 0.22.
National Research (NASDAQ:NRC – Get Free Report) last announced its earnings results on Tuesday, October 27th. The company reported $0.21 earnings per share for the quarter, topping analysts’ consensus estimates of $0.18 by $0.03. National Research had a net margin of 4.48% and a return on equity of 313.25%. The company had revenue of $38.40 million during the quarter, compared to the consensus estimate of $35.80 million. As a group, research analysts forecast that National Research Corporation will post 0.97 EPS for the current fiscal year.
National Research Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, January 8th. Investors of record on Tuesday, December 29th will be issued a $0.16 dividend. The ex-dividend date of this dividend is Tuesday, December 29th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.5%. National Research’s dividend payout ratio (DPR) is currently 228.57%.
Analyst Ratings Changes
NRC has been the topic of several recent analyst reports. Zacks Research raised National Research to a “hold” rating in a report on Monday, October 5th. Weiss Ratings upgraded National Research from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, October 28th. Wall Street Zen upgraded National Research from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, Citizens Jmp boosted their price objective on National Research from $26.00 to $27.00 and gave the stock a “market outperform” rating in a research note on Wednesday, October 28th. One analyst has rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, National Research presently has an average rating of “Hold” and an average target price of $27.00.
View Our Latest Stock Analysis on National Research
National Research Company Profile
National Research Corporation, formerly traded on the Nasdaq under the symbol NRC, provides research, analytics and performance-improvement services to the health care industry. Through its NRC Health business, the company helps hospitals, health systems and other care organizations understand and improve patient, consumer and employee experiences.
Its offerings have included patient and employee surveys, market research, reputation management, loyalty and engagement programs, benchmarking, and software tools that turn feedback and other data into operational insights.
Featured Articles
- Five stocks we like better than National Research
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Want to see what other hedge funds are holding NRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Research Corporation (NASDAQ:NRC – Free Report).
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.
